Olon S.p.A., an active pharmaceutical ingredients (API) contract development and manufacturing organization (CDMO) and generics supplier, has closed the acquisition of the manufacturing facility in Mahad, India.                                                                   Olon India will start definitively all the activities the next April 1st according to the strategy of Olon S.p.A.   “With this acquisition Olon achieved another successful milestone toward our growing strategy,” said...